AVROBIO Alpha and Beta Analysis
| AVRODelisted Stock | USD 1.40 0.04 2.78% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as AVROBIO. It also helps investors analyze the systematic and unsystematic risks associated with investing in AVROBIO over a specified time horizon. Remember, high AVROBIO's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to AVROBIO's market risk premium analysis include:
Beta (0) | Alpha 0.14 | Risk 0.0 | Sharpe Ratio 0.0 | Expected Return 0.0 |
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
AVROBIO |
AVROBIO Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. AVROBIO market risk premium is the additional return an investor will receive from holding AVROBIO long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in AVROBIO. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate AVROBIO's performance over market.| α | 0.14 | β | -0.0025 |
AVROBIO Fundamentals Vs Peers
Comparing AVROBIO's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze AVROBIO's direct or indirect competition across all of the common fundamentals between AVROBIO and the related equities. This way, we can detect undervalued stocks with similar characteristics as AVROBIO or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of AVROBIO's fundamental indicators could also be used in its relative valuation, which is a method of valuing AVROBIO by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare AVROBIO to competition |
| Fundamentals | AVROBIO | Peer Average |
| Return On Equity | 0.43 | -0.31 |
| Return On Asset | -0.35 | -0.14 |
| Current Valuation | (26.51 M) | 16.62 B |
| Shares Outstanding | 44.89 M | 571.82 M |
| Shares Owned By Insiders | 1.65 % | 10.09 % |
| Shares Owned By Institutions | 68.80 % | 39.21 % |
| Number Of Shares Shorted | 139.56 K | 4.71 M |
AVROBIO Opportunities
AVROBIO Return and Market Media
The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | AVROBIO Options Chain Prices 2024 - MarketBeat | 04/03/2024 |
2 | AVRO Stock Earnings Avrobio Beats EPS for Q1 2024 | 05/13/2024 |
3 | Avrobio executive buys shares worth over 970k | 05/15/2024 |
4 | Gabelli Funds LLC Invests 467000 in AVROBIO, Inc. - Defense World | 06/11/2024 |
5 | Tectonic, AVROBIO complete merger, announce 130.7M private placement | 06/20/2024 |
About AVROBIO Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including AVROBIO or other delisted stocks. Alpha measures the amount that position in AVROBIO has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
AVROBIO Upcoming Company Events
As portrayed in its financial statements, the presentation of AVROBIO's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, AVROBIO's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of AVROBIO's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of AVROBIO. Please utilize our Beneish M Score to check the likelihood of AVROBIO's management manipulating its earnings.
| 28th of March 2024 Upcoming Quarterly Report | View | |
| 9th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 28th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with AVROBIO
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Other Consideration for investing in AVROBIO Stock
If you are still planning to invest in AVROBIO check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the AVROBIO's history and understand the potential risks before investing.
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |